Pharmaceutical

Augustine secures $85m to advance Charcot-Marie-Tooth candidate

Augustine Therapeutics has raised €78m ($85m) in funding to support the development of its lead candidate as it enters a Phase I/II trial in Charcot-Marie-Tooth (CMT) disease.

Mar 25, 2025 - 06:00
Augustine secures $85m to advance Charcot-Marie-Tooth candidate
Augustine Therapeutics has raised €78m ($85m) in funding to support the development of its lead candidate as it enters a Phase I/II trial in Charcot-Marie-Tooth (CMT) disease.
Read the original article

Tags:

Previous Article

Rising Sirturo resistance highlights urgent need for new TB therapies

Next Article

FDA approves IND application for Everest’s cancer vaccine

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The biotech scorecard for the second quarter: 24 stock-moving events to watch

STAT+: The biotech scorecard for the second quarter: 24...

Apr 3, 2023

Opinion: After living with sickle cell disease for 39 years, I’m both excited and skeptical about the newly approved gene therapies

Opinion: After living with sickle cell disease for 39 y...

Dec 9, 2023

Cold chain storage and distribution for the pharmaceutical industry

Cold chain storage and distribution for the pharmaceuti...

May 21, 2024